AP3777A - - Google Patents

Info

Publication number
AP3777A
AP3777A AP201407413A AP201407413A AP3777A AP 3777 A AP3777 A AP 3777A AP 201407413 A AP201407413 A AP 201407413A AP 201407413 A AP201407413 A AP 201407413A AP 3777 A AP3777 A AP 3777A
Authority
AP
ARIPO
Application number
AP201407413A
Other languages
English (en)
Other versions
AP201407413A0 (en
Inventor
Arno Appavoo Enose
Harish Kumar Madan
Sumit Madan
Anupam Trehan
Puneet Tyagi
Vinod Kumar Arora
Original Assignee
Sun Pharmaceutical Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US13/183,119 priority Critical patent/US8664265B2/en
Priority to IN2703DE2011 priority
Priority to IN2156DE2012 priority
Application filed by Sun Pharmaceutical Industries Limited filed Critical Sun Pharmaceutical Industries Limited
Priority to PCT/IB2012/053614 priority patent/WO2013008218A1/en
Publication of AP201407413A0 publication Critical patent/AP201407413A0/xx
Application granted granted Critical
Publication of AP3777A publication Critical patent/AP3777A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y02A50/411
AP201407413A 2005-05-18 2012-07-13 AP3777A (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US13/183,119 US8664265B2 (en) 2005-05-18 2011-07-14 Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
IN2703DE2011 2011-09-19
IN2156DE2012 2012-07-12
PCT/IB2012/053614 WO2013008218A1 (en) 2011-07-14 2012-07-13 Stable dosage forms of arterolane and piperaquine

Publications (2)

Publication Number Publication Date
AP201407413A0 AP201407413A0 (en) 2014-02-28
AP3777A true AP3777A (es) 2016-08-31

Family

ID=47505579

Family Applications (1)

Application Number Title Priority Date Filing Date
AP201407413A AP3777A (es) 2005-05-18 2012-07-13

Country Status (10)

Country Link
EP (1) EP2731603A1 (es)
JP (1) JP2014522856A (es)
KR (1) KR20140053169A (es)
CN (1) CN103930107A (es)
AP (1) AP3777A (es)
AU (1) AU2012282077A1 (es)
CA (1) CA2850089A1 (es)
EA (1) EA201490233A8 (es)
MX (1) MX2014000463A (es)
WO (1) WO2013008218A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014132226A1 (en) 2013-02-28 2014-09-04 Ranbaxy Laboratories Limited Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006123314A2 (en) * 2005-05-18 2006-11-23 Ranbaxy Laboratories Limited Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
WO2007132438A2 (en) * 2006-05-17 2007-11-22 Ranbaxy Laboratories Limited Antimalarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486199B1 (en) 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US6825230B2 (en) 2002-06-21 2004-11-30 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trixolane antimalarials
US6906205B2 (en) 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006123314A2 (en) * 2005-05-18 2006-11-23 Ranbaxy Laboratories Limited Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
WO2007132438A2 (en) * 2006-05-17 2007-11-22 Ranbaxy Laboratories Limited Antimalarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SNYDER ET AL: "In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models", EXPERIMENTAL PARASITOLOGY, NEW YORK, NY, US, vol. 115, no. 3, 2 December 2006 (2006-12-02), pages 296 - 300, XP005724230 *
VALECHA NEENA ET AL: "Arterolane Maleate Plus Piperaquine Phosphate for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Comparative, Multicenter, Randomized Clinical Trial", CLINICAL INFECTIOUS DISEASES, vol. 55, no. 5, 14 May 2012 (2012-05-14), pages 663 - 671 URL, XP009163781 *

Also Published As

Publication number Publication date
WO2013008218A1 (en) 2013-01-17
CN103930107A (zh) 2014-07-16
EA201490233A8 (ru) 2015-01-30
AP201407413A0 (en) 2014-02-28
KR20140053169A (ko) 2014-05-07
EP2731603A1 (en) 2014-05-21
MX2014000463A (es) 2014-07-09
CA2850089A1 (en) 2013-01-17
JP2014522856A (ja) 2014-09-08
EA201490233A1 (ru) 2014-07-30
AU2012282077A1 (en) 2014-01-30

Similar Documents

Publication Publication Date Title
AP3853A (es)
AP2016009466A0 (es)
AR087616A1 (es) DRINK DISPENSER AMBULATING DEVICE
AR088268A1 (es) SYSTEMS AND METHODS FOR SUBSUELO OIL RECOVERY OPTIMIZATION
AR086875A1 (es) WIND ENERGY INSTALLATION TOWER
AR087716A1 (es) Composiciones reguladoras del crecimiento de plantas, metodos de preparacion y usos de las mismas
AR085856A1 (es) Formas cristalinas del acido (2s)-2-ter-butoxi-2-(4-(2,3-dihidropirano[4,3,2-de]quinolin-7-il)-2-metilquinolin-3-il)acetico
AR087885A1 (es) USEFUL ENZYMES FOR THE FOOD INDUSTRY
AR087198A1 (es) WATER BASED PROLAMINE COMPOSITIONS, METHODS FOR MANUFACTURING WATER BASED PROLAMINE COMPOSITIONS, AND THEIR APPLICATIONS
AR088786A1 (es) Compuestos de antranilamida y sus usos como plaguicidas
AR085396A1 (es) Medio de cultivo celular para exposicion uvc y metodos relacionados con el mismo
AP3936A (es)
AP3777A (es)
AR089277A1 (es) METHOD FOR PRODUCING STEEL PIPES FOR AIR BAG
AR079996A1 (es) A METHOD OF OBTAINING POWDERED NATURAL COLORANTS, THE COLORANTS SO OBTAINED AND THEIR APPLICATIONS
AR082798A1 (es) TURBO-ALTERNATOR FOR MOTORCYCLES AND CARS
AR082642A1 (es) Validacion de conjunto de sensor
AR081576A1 (es) Metodo para elaborar zapatos utilizando un sistema interactivo
AR081130A1 (es) INTAKE VALVE FOR INTERNAL COMBUSTION ENGINE
AR080119A4 (es) Dilatador y cateterizador uretral
AR080107A1 (es) COMPOSITION AND APPLICATION PROCESS OF ANTIMICOTIC LIQUID
AR080106A1 (es) Composiciones y metodos para restringir la colonizacion de uno o mas patogenos en el intestino de un vertebrado por medio de exclusion competitiva
AR080098A2 (es) Compuesto polimorfo cristalino del compuesto acido 6-(4-clorofenil)-2,2-dimetil-7-fenil-2,3 dihidro-1h-pirrolizin-5-ilacetico, composicion farmaceutica que lo comprende, su uso para preparar esta ultima y proceso para preparar dicho polimorfo cristalino
AR080095A4 (es) Placa con vectores de lectura de codigo de barras
AR080108A1 (es) A STABLE PHARMACEUTICAL COMPOSITION OF ORAL ADMINISTRATION THAT INCLUDES 4-AMINO-1 - [(2R, 5S) -2- (HYDROXIMETHYL) -1,3-OXATIOLAN-5-IL] -1,2-DIHYDROPIRIMIDINE-2-ONA, ACID ({[(2R) -1- (6-AMINO-9H-PURINA-9-IL) PROPAN-2-IL] OXI} METHYL) PHOSPHORIC AND 8-CHLORINE-5- (2-CYCLOPROPYLETINYL) -5- (TRIFLUOROMETIL ) -4-OXA-2-AZABICI